Displaying 1 - 5 of 5
  • Print
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
41 A3421 PACLITAXEL 6MG/ML INJ (FSB) (BQ) PACLITAXEL PACLITAXEL 50ML BQ 53.44 53.4422 VIAL 25 VIAL FSB FLAGSHIP BIOTECH ATB ANSA TRADING BARBADOS LTD 1000 ANTINEOPLASTICS 2024-04-01 2026-03-31 IV 6 ANTINEOPLASTICS
40 A3425 CYTAX 6MG/ML INJ (INP/AHI) PACLITAXEL PACLITAXEL CYTAX 50ML BQ 114.17 114.17 INJECTION 0 VIAL INP INTAS PHARMACEUTICALS LTD AHI ARMSTRONG HEALTHCARE INC 1000 ANTINEOPLASTICS 2022-04-01 2024-03-31 IV 0 ANTINEOPLASTICS
41 A3428 PACLITAXEL 6MG/ML INJ (KWA) (BQ) PACLITAXEL PACLITAXEL 50ML BQ 63.77 63.7719 VIAL 25 VIAL KWA KWALITY PHARMACEUTICALS ATB ANSA TRADING BARBADOS LTD 1000 ANTINEOPLASTICS 2024-04-01 2026-03-31 IV 6 ANTINEOPLASTICS
40 A342B PACLITAXEL 6MG/ML INJ (KWL/RXP) PACLITAXEL PACLITAXEL 50ML BQ 88.62 88.62 INJECTION 0 VIAL KWL KHANDELWAL LABS RXP RX PRO INC 1000 ANTINEOPLASTICS 2022-04-01 2024-03-31 IV 0 ANTINEOPLASTICS
41 A342E ZAXOL 6MG/ML INJ (ZUV) PACLITAXEL PACLITAXEL ZAXOL 50ML BQ 64.48 64.4786 VIAL 25 VIAL ZUV ZUVIUS PHA PHARMACY SALES CARIBBEAN B 1000 ANTINEOPLASTICS 2024-04-01 2026-03-31 IV 6 ANTINEOPLASTICS 2024-02-08